Research Development - Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) - Alpha Spread
F

Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Watchlist
Price: 34.72 AUD -1.03% Market Closed
Market Cap: 20.3B AUD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Fisher & Paykel Healthcare Corporation Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fisher & Paykel Healthcare Corporation Ltd
Research & Development Peer Comparison

Comparables:
T
TRU

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
F
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Research & Development
-NZ$198.2m
CAGR 3-Years
-13%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
T
Truscreen Group Ltd
ASX:TRU
Research & Development
-NZ$877.3k
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is Fisher & Paykel Healthcare Corporation Ltd's Research & Development?
Research & Development
-198.2m NZD

Based on the financial report for Mar 31, 2024, Fisher & Paykel Healthcare Corporation Ltd's Research & Development amounts to -198.2m NZD.

What is Fisher & Paykel Healthcare Corporation Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-15%

Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for Fisher & Paykel Healthcare Corporation Ltd have been -13% over the past three years , -15% over the past five years .

Back to Top